South Korea okays Pfizer's Covid vax for ages 5-11
23 Feb 2022 5:42 PM GMT
Seoul: South Korean health officials on Wednesday approved Pfizer's COVID-19 vaccine for children aged 5 to 11, expanding the country's immunisation programme in the face of a massive Omicron outbreak that is driving up hospitalisations and deaths.
The Korea Disease Control and Prevention Agency reported a record 171,452 new virus cases on Wednesday, nearly a 40-fold increase from levels in mid-January when Omicron first emerged as the country's dominant strain.
The 99 new deaths were the highest daily tally since Dec. 31, when the country was grappling with a delta-driven surge.
Next Story
